scispace - formally typeset
N

Natascia Crispino

Researcher at National Institutes of Health

Publications -  5
Citations -  340

Natascia Crispino is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Agonist & Hypertonic saline. The author has an hindex of 4, co-authored 4 publications receiving 320 citations. Previous affiliations of Natascia Crispino include Imperial College London.

Papers
More filters
Journal ArticleDOI

Theobromine inhibits sensory nerve activation and cough

TL;DR: Theobromine, a methylxanthine derivative present in cocoa, effectively inhibits citric acid‐induced cough in guinea‐pigs in vivo and may form the basis for a new class of antitussive drugs.
Journal ArticleDOI

Inhibition of guinea‐pig and human sensory nerve activity and the cough reflex in guinea‐pigs by cannabinoid (CB2) receptor activation

TL;DR: Analysis of inhibitory actions of cannabinoids on sensory nerve depolarisation mediated by capsaicin, hypertonic saline and PGE2 on isolated guinea‐pig and human vagus nerve preparations, and the cough reflex in conscious guinea-pigs suggests that the development of CB2 agonists, devoid of CB1‐mediated central effects, will provide a new and safe antitussive treatment for chronic cough.
Journal ArticleDOI

Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways

TL;DR: Sensory nerves regulate central and local reflexes such as airway plasma protein leakage, bronchoconstriction and cough and may be enhanced during inflammation such that these protective effects become exacerbated and deleterious.
Journal ArticleDOI

Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD

TL;DR: D dopamine receptor ligands inhibit depolarization of the rat and human vagus and suggest that dopamine receptor agonists may be of therapeutic benefit in the treatment of symptoms such as cough and mucus secretion which are evident in respiratory diseases such as asthma and chronic obstructive pulmonary disease.
Journal ArticleDOI

Peripheral arthritis in psoriatic arthritis: from immunopathogenesis to therapy with Janus kinase inhibitors.

TL;DR: In this paper , the authors discuss the rationale for using approved JAK inhibitors for treatment of peripheral PsA and their positioning in the context of EULAR/GRAPPA guidelines.